ezogabine has been researched along with methoctramine in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (methoctramine) | Trials (methoctramine) | Recent Studies (post-2010) (methoctramine) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 332 | 1 | 32 |
| Protein | Taxonomy | ezogabine (IC50) | methoctramine (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.9772 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0315 | |
| Acetylcholinesterase | Homo sapiens (human) | 5.3703 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, S; Drobny, H; Kosenburger, K; Kubista, H; Mahlknecht, P | 1 |
1 other study(ies) available for ezogabine and methoctramine
| Article | Year |
|---|---|
Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.
Topics: Acetylcholine; Action Potentials; Adrenergic Fibers; Animals; Animals, Newborn; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Carbamates; Cells, Cultured; Diamines; Dose-Response Relationship, Drug; Electric Stimulation; KCNQ Potassium Channels; Muscarinic Agonists; Muscarinic Antagonists; Neural Inhibition; Norepinephrine; omega-Conotoxin GVIA; Oxotremorine; Pertussis Toxin; Phenylenediamines; Pirenzepine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Presynaptic; Superior Cervical Ganglion; Synaptic Transmission; Time Factors; Type C Phospholipases | 2009 |